Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Observational Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
Conditions
Interventions
Not applicable (no therapy is administered as part of this study)
Locations
62
United States
Research Site
Birmingham, Alabama, United States
Research Site
Oro Valley, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Tucson, Arizona, United States
Research Site
Canoga Park, California, United States
Research Site
Carmichael, California, United States
Start Date
September 19, 2016
Primary Completion Date
October 31, 2019
Completion Date
October 31, 2019
Last Updated
April 17, 2020
NCT07153471
NCT07351968
NCT06381791
NCT06747494
NCT07327931
NCT06906939
Lead Sponsor
Biosplice Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions